Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center.

[1]  K. Shimoda,et al.  Outcome of allogeneic hematopoietic cell transplantation in patients with adult T‐cell leukemia , 2018, Hematological oncology.

[2]  A. Phillips,et al.  Adult T Cell Leukemia-Lymphoma (ATL): State of the Art , 2018, Current Hematologic Malignancy Reports.

[3]  G. Barber,et al.  Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. , 2018, Blood advances.

[4]  K. Tobinai,et al.  A Review of New Findings in Adult T-cell Leukemia–Lymphoma: A Focus on Current and Emerging Treatment Strategies , 2018, Advances in Therapy.

[5]  S. Yamasaki,et al.  Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis , 2018, Bone Marrow Transplantation.

[6]  T. Miyamoto,et al.  Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  K. Ishitsuka,et al.  Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma. , 2017, Journal of clinical and experimental hematopathology : JCEH.

[8]  M. Seto,et al.  Newly identified poor prognostic factors for adult T-cell leukemia–lymphoma treated with allogeneic hematopoietic stem cell transplantation , 2017, Leukemia & lymphoma.

[9]  A. Phillips.  Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate? , 2017, Leukemia & lymphoma.

[10]  A. Bazarbachi,et al.  Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant? , 2016, Bone Marrow Transplantation.

[11]  Ling Zhang,et al.  Adult T-Cell Leukemia/Lymphoma: Rarely Encountered in the United States. , 2016, Clinical lymphoma, myeloma & leukemia.

[12]  A. Verma,et al.  Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy , 2016, Oncotarget.

[13]  S. Hanada,et al.  Treatment and survival among 1594 patients with ATL. , 2015, Blood.

[14]  Shinsuke Suzuki,et al.  A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  M. Seto,et al.  Recent advances in the treatment of adult T-cell leukemia-lymphomas , 2015, Cancer science.

[16]  K. Ishitsuka,et al.  Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. , 2014, The Lancet. Oncology.

[17]  Daniela Eberhardt.  Together is better , 2013 .

[18]  A. Bazarbachi,et al.  Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment , 2012, Leukemia research and treatment.

[19]  T. Casci.  Gene regulation: Together, for better , 2011, Nature Reviews Genetics.

[20]  K. Matsuo,et al.  Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. , 2010, Blood.

[21]  S. Horwitz,et al.  A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients , 2009, Leukemia & lymphoma.

[22]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[23]  M. Tomonaga,et al.  Survey of Anti‐human T‐Cell Leukemia Virus Type I Antibody in Family Members of Patients with Adult T‐Cell Leukemia , 1990, Japanese journal of cancer research : Gann.